title: A PoTENtial Antidote: A Prohemostatic Factor Xa Variant for Reversal of Direct Oral Anticoagulants.
authors.affiliation: From the Departments of Medicine (J.C.F., J.I.W.) and Biochemistry and Biomedical Sciences (J.I.W.) and The Thrombosis and Atherosclerosis Research Institute (J.C.F., J.I.W.), McMaster University, Hamilton, ON, Canada.
authors.forename: James C
authors.initials: JC
authors.lastname: Fredenburgh
authors.affiliation: From the Departments of Medicine (J.C.F., J.I.W.) and Biochemistry and Biomedical Sciences (J.I.W.) and The Thrombosis and Atherosclerosis Research Institute (J.C.F., J.I.W.), McMaster University, Hamilton, ON, Canada. weitzj@taari.ca.
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants; D000931:Antidotes; D015951:Factor Xa; D006470:Hemorrhage; D006801:Humans; D011994:Recombinant Proteins
chemical_list: D000925:Anticoagulants; D000931:Antidotes; D011994:Recombinant Proteins; D015951:Factor Xa